2020plus
2020plus classifies genes as oncogenes, tumor suppressor genes, or non-driver genes using small somatic variant data and a Random Forest machine learning framework.
Key Features:
- Random Forest Classification: Applies a Random Forest ensemble learning algorithm to analyze somatic mutation data for driver gene prediction.
- Ratiometric Machine Learning Approach: Uses a machine-learning-based ratiometric strategy to improve classification accuracy of cancer driver genes.
- Driver Gene Categorization: Distinguishes oncogenes, tumor suppressor genes, and non-driver genes based on patterns of small somatic variants.
- Performance Evaluation Framework: Operates within a benchmarking framework that evaluates driver gene prediction methods and compares multiple computational approaches.
- Mutation Rate Variability Analysis: Examines the impact of unexplained variability in mutation rates on false-positive driver gene predictions.
Scientific Applications:
- Cancer Genomics: Supports identification and classification of cancer driver genes involved in tumorigenesis.
- Somatic Mutation Analysis: Enables analysis of somatic mutation datasets to evaluate gene roles in cancer development.
- Method Evaluation in Driver Gene Prediction: Facilitates comparison and benchmarking of computational approaches for cancer driver gene identification.
Methodology:
The tool applies a Random Forest machine learning model with a ratiometric feature-based approach to analyze somatic mutation data and classify genes into oncogenes, tumor suppressor genes, or non-driver genes while evaluating prediction performance across computational methods.
Topics
Details
- License:
- Apache-2.0
- Maturity:
- Mature
- Cost:
- Free of charge
- Tool Type:
- command-line tool, workflow
- Operating Systems:
- Linux
- Programming Languages:
- Python
- Added:
- 2/8/2019
- Last Updated:
- 11/25/2024
Operations
Publications
Tokheim CJ, Papadopoulos N, Kinzler KW, Vogelstein B, Karchin R. Evaluating the evaluation of cancer driver genes. Proceedings of the National Academy of Sciences. 2016;113(50):14330-14335. doi:10.1073/pnas.1616440113. PMID:27911828. PMCID:PMC5167163.
PMID: 27911828
PMCID: PMC5167163
Funding: - HHS | NIH | National Cancer Institute: 1U24CA204817-01, 5U01CA180956-03, F31CA200266, P50-CA62924
Documentation
Downloads
- Source codehttps://github.com/KarchinLab/2020plus